Clinical Study of ICP-192 in Solid Tumors Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jin Li, PhD
Shanghai East Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Not, yet, recruiting - Henan Cancer Hospital & Affiliated Tumor Hospital of Zhengzhou University
Zhengzhou, Henan, China
Not, yet, recruiting - Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine ,central South University
Changsha, Hunan, China
Not, yet, recruiting - the Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Not, yet, recruiting - the First Bethune Hospital of Jilin University
Changchun, Jilin, China
Not, yet, recruiting - Shanghai East Hospital
Shanghai, Shanghai Municipality, China
Recruiting - Cancer Hospital of the University of Chinese Academy of Sciences
Hangzhou, Zhejiang, China
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Dec 2018
- Primary completion
- 31 Dec 2024
- Completion
- 31 Dec 2024
- Last update posted
- 6 Jul 2022
- Registered enrollment
- 56
- Registry id
- NCT03758664
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.